Pilot Therapeutics Holdings IncOver The Counter Market:PLTT
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pilot Therapeutics Holdings Inc | 1.2K | 0.0x | --- |
Petlife Pharmaceuticals Inc | 19.7K | 0.0x | --- |
Cannabis Suisse Corp | 311.0K | -0.9x | --- |
Medican Enterprises Inc | 38.9K | 0.0x | --- |
Sunset Island Group Inc | 590.0 | 0.0x | --- |
Lucy Scientific Discovery Inc | 880.0 | 0.0x | --- |
Company Information
Pilot Therapeutics Holdings, Inc. is a holding company for Pilot Therapeutics, Inc. and is a specialty pharmaceutical company. Through lipid profiling and metabolism, the Company has developed a proprietary, lipid and genomic profiling research platform, termed Functional Liponomics. Using Functional Liponomics, the Company is developing novel, branded, therapeutic, pharmaceutical and over-the-counter (OTC) medical food products that are specifically designed to address dysfunctional lipid metabolism in chronic human diseases such as asthma, coronary heart disease, allergic rhinitis, cancer, cystic acne and rheumatoid arthritis. Pilot expects to launch its first product, Airozin, for adults and children regionally in April 2003 and nationally by 2004.
Contact Information
- Headquarters
- 101 N. Chestnut Street, Suite 102WINSTON SALEM, NC, United States 27101
- Phone
- 336-725-2222
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Terrance Little
- President
- Keith Wakeman
- Chief Executive Officer
- Ross Consaul
- Chief Financial Officer
- Steven Greenberg
- Chief Technology Officer, Director
- Floyd Chilton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 11.5M |
Pilot Therapeutics Holdings Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.54 |
Book Value | $-0.52 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
